End-to-End Services
Discovery and Translation of PARP Inhibitors
Explore our in vitro and in vivo platforms for DNA repair and targeted therapy evaluation.
Organoids
Organoids for PARP Inhibitors
Patient-derived organoids model DNA repair deficiency and synthetic lethality, supporting predictive efficacy and resistance studies.
PDX Models
Translational In Vivo Models
Crown Bioscience’s expansive PDX collection includes BRCA, PALB2, and HRD-positive tumors to evaluate efficacy, dosing, and resistance mechanisms in clinically relevant settings.
.webp)
